Commercial-stage medical technology company Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) Inc has shared results from a new study published in the Annals of Surgical Oncology.
Peer-reviewed research provided a comprehensive and up-to-date understanding of population-level reoperation rates and incremental healthcare costs associated with patients who require reoperations after undergoing breast-conserving surgery (BCS).
Specifically, investigators at The University of Texas Health Science Center and The University of Texas MD Anderson Cancer Center concluded that more attention and continuing efforts should be made to reduce reoperation rates.
Adrian Mendes, Perimeter's chief executive officer, said: "Our work strives to address the significant costs and negative patient outcomes due to operations.
"By providing innovative, intraoperative imaging technologies, our goal is that no patient has to go through the emotional and physical trauma of a second surgery due to cancer left behind."
Researchers MD Anderson, one of the world's leading cancer research centers, identified 17,129 commercially insured women aged 18-64 and 6,977 Medicare beneficiaries aged 18 and older who had initial breast-conserving surgery between 2017 and 2019.
The one-year follow-up revealed reoperation rates of 21.1% among commercially insured women and 14.9% among the Medicare cohort.
These reoperations correlated with a 24% increase in costs for both the commercial and Medicare cohorts, translating into incremental expenses of $21,607 and $8,559, respectively.
Furthermore, reoperations were linked to a 54% increased risk of complications in the commercial cohort and an 89% elevated risk in the Medicare cohort.